Hypersomnia (organic)
"Hypersomnia (organic)" References in the ICD-10-CM Index to Diseases and Injuries
References in the ICD-10-CM Index to Diseases and Injuries applicable to the clinical term "hypersomnia (organic)"
- Hypersomnia (organic) - G47.10 Hypersomnia, unspecified
- due to
- alcohol
- amphetamines
- caffeine
- cocaine
- drug NEC
- abuse - F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
- dependence - F19.282 Other psychoactive substance dependence with psychoactive substance-induced sleep disorder
- use - F19.982 Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder
- medical condition - G47.14 Hypersomnia due to medical condition
- mental disorder - F51.13 Hypersomnia due to other mental disorder
- opioid
- psychoactive substance NEC
- abuse - F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
- dependence - F19.282 Other psychoactive substance dependence with psychoactive substance-induced sleep disorder
- use - F19.982 Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder
- sedative, hypnotic, or anxiolytic
- abuse - F13.182 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder
- dependence - F13.282 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder
- use - F13.982 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder
- stimulant NEC
- idiopathic - G47.11 Idiopathic hypersomnia with long sleep time
- nonorganic origin - F51.11 Primary hypersomnia
- specified NEC - F51.19 Other hypersomnia not due to a substance or known physiological condition
- not due to a substance or known physiological condition - F51.11 Primary hypersomnia
- specified NEC - F51.19 Other hypersomnia not due to a substance or known physiological condition
- primary - F51.11 Primary hypersomnia
- recurrent - G47.13 Recurrent hypersomnia
- specified NEC - G47.19 Other hypersomnia
- due to
Applicable Clinical Terms Definitions
Amphetamines: Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.
Caffeine: A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.
Cocaine: An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.
Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.